Sphere–like aggregates of porphyrin as phototherapeutic agent for synergistic cancer treatment
Source abstract
Abstract
Abstract Nowadays, “all–in–one” nano–agent combing various phototherapeutic effects into one nano–system has been attracted more attention in cancer therapy. Herein, a new kind of photosensitizers (PSs) aggregate is designed and constructed. Tetra (4–carboxy phenyl) porphyrin (TCPP), acted as element, is used to form a sphere–like TCPP nanoparticles (TNP) by the self–assembly process. The obtained TNP not only shows good hydrophilia, but also possesses a high photothermal conversion efficiency (η = 31%) which the excessive energy from the excited singlet state (Sn) to the ground state (S0) can be converted into heat. Moreover, TNP is served as photodynamic therapy (PDT) agent because of their components. The synergistic effect of PDT and photothermal therapy (PTT) gives TNP to superior antitumor performance under NIR laser irradiation. Meanwhile, TNP also exhibit an excellent biocompatible and safe for biomedical applications. This work provides novel insight for developing an outstanding phototherapeutic agent based on PSs aggregates to synergistically treat cancer.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (60)
Show source-provided references
1. Global cancer statistics
2. Cancer statistics
3. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
4. Assembly of Au plasmonic photothermal agent and iron oxide nanoparticles on ultrathin black phosphorus for targeted photothermal and photodynamic cancer therapy10.1002/adfm.201700371 ↗
5. Chemotherapeutic drug based metal–organic particles for microvesicle–mediated deep penetration and programmable pH/NIR/hypoxia activated cancer photochemotherapy10.1002/advs.201700648 ↗
6. Enhanced cisplatin chemotherapy by iron oxide nanocarrier–mediated generation of highly toxic reactive oxygen species10.1021/acs.nanolett.6b04269 ↗
7. Self–assembled zinc phthalocyanine nanoparticles as excellent photothermal/photodynamic synergistic agent for antitumor treatment10.1016/j.cej.2018.12.007 ↗
8. Reductive surfactant–assisted one–step fabrication of a BiOI/BiOIO3 heterojunction biophotocatalyst for enhanced photodynamic theranostics overcoming tumor hypoxia10.1039/C8NH00440D ↗
9. Bismuth ferrite–based nanoplatform design: an ablation mechanism study of solid tumor and nir–triggered photothermal/photodynamic combination cancer therapy10.1002/adfm.201706827 ↗
10. Amorphous Fe–based nanoagents for self‐enhanced chemodynamic therapy by re–establishing tumor acidosis
11. Construction of Bi/phthalocyanine manganese nanocomposite for trimodal imaging directed photodynamic and photothermal therapy mediated by 808 nm light10.1016/j.biomaterials.2019.119569 ↗
12. Supramolecular photosensitizers rejuvenate photodynamic therapy10.1039/C7CS00594F ↗
13. J. Huang J. Yoon Phthalocyanines as medicinal photosensitizers: developments in the last five years10.1016/j.ccr.2017.08.003 ↗
14. Lanthanide–activated phosphors based on 4f–5d optical transitions: theoretical and experimental aspects10.1021/acs.chemrev.6b00691 ↗
15. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics10.1021/acs.chemrev.5b00244 ↗
16. Near–infrared excited orthogonal emissive upconversion nanoparticles for imaging–guided on–demand therapy10.1021/acsnano.9b04200 ↗
17. Rational design of multifunctional Fe@γ–Fe2O3@H–TiO2 nanocomposites with enhanced magnetic and photoconversion effects for wide applications: from photocatalysis to imaging–guided photothermal cancer therapy10.1002/adma.201706747 ↗
18. Biocompatible Iron phthalocyanine–albumin assemblies as photoacoustic and thermal theranostics in living mice10.1021/acsami.7b04360 ↗
19. Thiol–capped Bi nanoparticles as stable and all–in–one type theranostic nanoagents for tumor imaging and thermoradiotherapy10.1016/j.biomaterials.2018.01.047 ↗
20. Multifunctional bismuth ferrite nanocatalysts with optical and magnetic functions for ultrasound–enhanced tumor theranostics10.1021/acsnano.0c02458 ↗
21. Right Cu2–xS@MnS core–shell nanoparticles as a photo/H2O2–responsive platform for effective cancer theranostics10.1002/advs.201901461 ↗
22. Intelligent hollow Pt–CuS janus architecture for synergistic catalysis–enhanced sonodynamic and photothermal cancer therapy10.1021/acs.nanolett.9b01595 ↗
23. Enhanced NH3–sensing behavior of 2,9,16,23–tetrakis (2,2,3,3–tetra fluoropropoxy) metal(II) phthalocyanine/multi–walled carbon nanotube hybrids: an investigation of the effects of central metals10.1016/j.carbon.2014.08.065 ↗
24. Porphyrin–phospholipid liposomes permeabilized by near–infrared light
25. Adenosine Triphosphate templated self–assembly of cationic porphyrin into chiral double superhelices and enzyme–mediated disassembly10.1021/jacs.9b04133 ↗
26. Nanozymes–engineered metal–organic frameworks for catalytic cascades–enhanced synergistic cancer therapy10.1021/acs.nanolett.9b02253 ↗
27. Small−molecule porphyrin−based organic nanoparticles with remarkable photothermal conversion efficiency for in vivo photoacoustic imaging and photothermal therapy10.1021/acsami.9b06866 ↗
28. Self−assembled naphthalimide conjugated porphyrin nanomaterials with D–A structure for PDT/PTT synergistic therapy10.1021/acs.bioconjchem.9b00819 ↗
29. Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy10.1016/j.dyepig.2020.108664 ↗
30. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
31. In vivo imaging–guided photothermal/photoacoustic synergistic therapy with bioorthogonal metabolic glycoengineering–activated tumor targeting nanoparticles10.1021/acsnano.7b03226 ↗
32. Nanostructured phthalocyanine assemblies with protein–driven switchable photoactivities for biophotonic imaging and therapy10.1021/jacs.7b05916 ↗
33. New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates10.1039/C7SC05115H ↗
34. Phthalocyanine–aggregated polymeric nanoparticles as tumor–homing near–infrared absorbers for photothermal therapy of cancer10.7150/thno.4133 ↗
35. The enhanced photothermal effect of graphene/conjugated polymer composites: photoinduced energy transfer and applications in photocontrolled switches10.1039/C4CC06849A ↗
36. Copper selenide nanocrystals for photothermal therapy10.1021/nl201400z ↗
37. A metal–semiconductor nanocomposite as an efficient oxygen–independent photosensitizer for photodynamic tumor therapy10.1039/C7NH00087A ↗
38. High–throughput synthesis of single–layer MoS2 nanosheets as a near–infrared photothermal–triggered drug delivery for effective cancer therapy10.1021/nn501647j ↗
39. Flower–like PEGylated MoS2 nanoflakes for near–infrared photothermal cancer therapy10.1038/srep17422 ↗
40. Synthesis of biladienone and bilatrienone by coupled oxidation of tetraarylporphyrins10.1021/jo070692a ↗
41. Zirconium–metalloporphyrin PCN–222: mesoporous metal–organic frameworks with ultrahigh stability as biomimetic catalysts10.1002/anie.201204475 ↗
42. Reversible multiphase transition in a bioMOF and its distinctive luminescence turn–on in alcohol vapor10.1021/acsami.9b14121 ↗
43. A Full–spectrum metal–free porphyrin supramolecular photocatalyst for dual functions of highly efficient hydrogen and oxygen evolution
44. NIRF/PA/CT multi–modality imaging guided combined photothermal and photodynamic therapy based on tumor microenvironment–responsive nanocomposites10.1039/C8TB00859K ↗
45. Photocatalysis enhancement for programmable killing of hepatocellular carcinoma through self–compensation mechanisms based on black phosphorus quantum–dot–hybridized nanocatalysts10.1021/acsami.8b21820 ↗
46. Black phosphorus nanosheet–based drug delivery system for synergistic photodynamic/photothermal/chemotherapy of cancer10.1002/adma.201603864 ↗
47. A magnetofluorescent carbon dot assembly as an acidic H2O2–driven oxygenerator to regulate tumor hypoxia for simultaneous bimodal imaging and enhanced photodynamic therapy10.1002/adma.201706090 ↗
48. MnO2–disguised upconversion hybrid nanocomposite: an ideal architecture for tumor microenvironment–triggered ucl/mr bioimaging and enhanced chemodynamic therapy10.1021/acs.chemmater.9b00893 ↗
49. Atomic–level nanorings (A–NRs) therapeutic agent for photoacoustic imaging and photothermal/photodynamic therapy of cancer10.1021/jacs.9b11553 ↗
50. Hyaluronic acid–targeted and pH–responsive drug delivery system based on metal–organic frameworks for efficient antitumor therapy10.1016/j.biomaterials.2019.119473 ↗
51. Self–assembled CeVO4/Ag nanohybrid as photoconversion agents with enhanced solar–driven photocatalysis and NIR–responsive photothermal/photodynamic synergistic therapy performance10.1039/C9NR02412C ↗
52. Large–pore mesoporous–silica–coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy10.1002/adma.201802479 ↗
53. Molecular interactions in organic nanoparticles for phototheranostic applications10.1021/acs.chemrev.5b00140 ↗
54. Helical self‐assembly of optically active phthalocyanine derivatives: effect of Zn–O coordination bond on morphology and handedness of nanostructures10.1002/cphc.201300604 ↗
55. Doxorubicin–conjugated CuS nanoparticles for efficient synergistic therapy triggered by near–infrared light10.1039/C5DT04842G ↗
56. Switchable up–conversion luminescence bioimaging and targeted photothermal ablation in one core–shell–structured nanohybrid by alternating near–infrared light10.1039/C8DT04871A ↗
57. Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells10.1021/nn1035262 ↗
58. Reactive oxygen species (ROS)−based nanomedicine10.1021/acs.chemrev.8b00626 ↗
59. The outcome of 5−ALA−mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase−110.1002/biof.129 ↗
60. New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates10.1039/C7SC05115H ↗